NEW YORK (Reuters) - Wyeth on Tuesday says it expects to shift marketing away from blockbuster depression drug Effexor this year and instead focus on newer treatment Pristiq, a recently approved ...
October 25, 2006 — The US Food and Drug Administration (FDA) and Wyeth Pharmaceuticals Inc have notified healthcare professionals via letter regarding the potential increased risk for fatal outcome ...
April 10 (Reuters) - Pfizer (PFE.N), opens new tab subsidiary Wyeth has agreed to pay $39 million to resolve claims from drug purchasers that it conspired with rival Teva to delay launching a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback